Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

McCarthy, EM; Sutton, E; Nesbit, S; White, J; Parker, B; Jayne, D; Griffiths, B; ... British Isles Lupus Assessment Group Biologics Register, BILAGBR; + view all McCarthy, EM; Sutton, E; Nesbit, S; White, J; Parker, B; Jayne, D; Griffiths, B; Isenberg, DA; Rahman, A; Gordon, C; D'Cruz, DP; Rhodes, B; Lanyon, P; Vital, EM; Yee, C-S; Edwards, CJ; Teh, L-S; Akil, M; McHugh, NJ; Zoma, A; Bruce, IN; British Isles Lupus Assessment Group Biologics Register, BILAGBR; - view fewer (2018) Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology , 57 (3) pp. 470-479. 10.1093/rheumatology/kex395 . Green open access

https://ift.tt/2Qqmfh4